Biomarkers

Next-Gen Protein Microarrays: The Future of Biomarker Discovery?

The Beginning of a Beautiful Friendship: Clinical Diagnostics & Drug Development

How to Outsource Development of Clinical Diagnostic Assay

Make Your Own Cancer Diagnostic Test: It's Easier Than You Think

Test - Biomarker Imaging for Preclinical Cancer Research

Advancing Metabolic Disease Drug Development: Translational Models and a GLP-1 Receptor Agonist Metabolism Case Study

Improving Translational Decision-Making through Disease-Relevant Preclinical Models in Pulmonary Fibrosis and Pain Drug Discovery

Protein Complex Biomarkers: Quantify NLRP3 Inflammasome Assembly and Activity Levels from Clinical Samples

From Skull to Deep Brain: Exploring Brain Dynamics with Intravital Imaging

Biomarkers Before the Assay: Sample Strategy and Signal Integrity

Measuring Target Protein Degradation in PBMCs: A KIF22 Pharmacodynamic Biomarker for the Clinic

Enhancing Clinical Predictability through Human Disease-relevant Preclinical Models in CNS and Muscle Drug Discovery

Plasma Proteomics: The Next Frontier of Biomarker Discovery in the Precision Medicine Era

#ExpertAnswers: Arutha Kulasinghe on Single-Cell Spatial Phenotyping for Biomarker Discovery

#ExpertAnswers: Mirka Allerding and Anna Sophie Skof on Indivumed Services' Cell-Free Plasma Biobank

#ExpertAnswers: Jeffrey Silva and Matthew Stokes on Mass Spectrometry-Based Proteomics

#ExpertAnswers: Artur Fedorowoski on Cardiovascular Dysautonomia in Post-COVID-19

#ExpertAnswers: Rajendra Kumari and Gera Goverse on the Cancer Immunity Cycle

Industry Insights with Crown Bioscience: In Vitro Technologies for Studying the Cancer-Immunity Cycle

#ExpertAnswers: Bonnie Lun on Single-Domain Antibodies for Research

#ExpertAnswers: Peter Ansell and Marian Navratil on Gene Expression Profiling

#ExpertAnswers: Yuning Chen on Antibody Production

#ExpertAnswers: Anuj Kalsy and Robert Snyder On The Variant-Rich Biobank